Geneiq LLC

Geneiq LLC was paid $402K by Medicaid between Jun 2020 and May 2023, across 19 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 55% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#101 of 436

Median peer was paid$17K

This provider vs. median23×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	4,892	$62K
2021	9,397	$145K
2022	7,534	$192K
2023	69	$3K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	55%	11,231	6,239	$222K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	12%	6,315	3,890	$48K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	7.0%	328	298	$28K
81226		5.9%	430	387	$24K
81225		4.2%	408	363	$17K
81306		2.7%	251	231	$11K
81227		2.3%	376	340	$9K
81231		2.1%	347	312	$8K
81232		1.8%	261	240	$7K
81328		1.8%	260	239	$7K
81335		1.7%	256	237	$7K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.7%	513	474	$7K

7 more codes

0001A		<1%	326	$2K
81291		<1%	126	$1K
81241		<1%	96	$1K
0002A		<1%	244	$1K
81240		<1%	96	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	0%	14	$0.00
87634		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOWARD, FRANK (CEO)